Browsing Tag
zilovertamab vedotin
1 post
Merck initiates Phase 3 waveLINE-010 trial for zilovertamab vedotin in diffuse large B-cell lymphoma
Merck, known as MSD outside the United States and Canada, has launched its pivotal Phase 3 waveLINE-010 clinical…